Research Logs & Open Questions
Where the Charter sets the mandate to engineer the future, the research logs are how that mandate is executed day to day. Each log tracks one live question across the directorate's standing domains — adverse-event suppression, pharmacology, behavioral systems, strain engineering, population surveillance, and the classified programs — with a lead investigator, a status, and an abstract that updates as the work matures.
Active Research Logs
Seven threads are open against the current research cycle. Status badges reflect PANACEA's last assessment of each log: ok on track, info early or observational, warn blocked or flagged for review.
PAN-RL-2091-008
● On track
Compliance-conditioning durability, Cohort VII
Logged 2091-02-03 · Lead: Dr. Priya Anand, Behavioral Systems
Deference-conditioning (Verdict program) in the Cohort VII subject lines is holding through a third dosing cycle, with measured compliance up sharply over the unconditioned control. Baseline cognition has not regressed, which had been the standing fear. The open question is whether the effect survives at the sub-threshold doses required for ambient population delivery.
PAN-RL-2091-011
● Flagged
Sub-threshold ambient dosing & dissent suppression
Logged 2091-03-12 · Lead: Dr. Marcus Vey, Population Surveillance
Populations exposed to field-realistic sub-threshold doses of the Docilis agent show measurably reduced propensity to organize, with no acute symptoms — the effect is subtle enough to evade any clinical screen. Flagged: the dose-response curve is non-linear, and the ambient concentration that suppresses dissent sits uncomfortably close to one that suppresses everything.
PAN-RL-2091-014
● On track
VITALNET sentiment-cluster classification
Logged 2091-03-27 · Lead: PANACEA, Behavioral Systems
PANACEA's sentiment model now separates idle complaint from organizing intent with high confidence across the mesh, and has begun resolving pre-mobilization "ignition" as a distinct signature hours ahead of a movement going public. Early correlation against later unrest is promising. The open question is generalization across cultures with divergent expression.
PAN-RL-2091-017
● On track
Compliance-aerosol potency assay, Series C
Logged 2091-04-09 · Lead: Dr. Lena Sørensen, Pharmacology
Series C assays quantify the active fractions of the CA-9 compliance aerosol across the BCL-3 and BCL-4 panel, with reproducible potency now achievable from stockpiled batches. The euphoric-pacifier fraction isolated last cycle holds up under the new protocol. A marketed spin-off (anxiolytic) is pending Legal & Compliance sign-off as a public-facing cover product.
PAN-RL-2091-021
● Observational
Subliminal neural-cue signaling, Halo Dream
Logged 2091-05-02 · Lead: Dr. Marcus Vey, Behavioral Systems
An observational study of whether the Halo Dream sleep tier can seed a subliminal cue that a subject acts on by morning without recalling its source. The effect is at the edge of instrument sensitivity and may be an artifact, so the log is held at observational status pending a controlled replication. See Neuroactive Enhancements.
PAN-RL-2091-024
● Restricted
Loyalty-firmware conditioning study Classified
Logged 2091-05-20 · Lead: Dr. Soren Vale (SHEPHERD), Directorate
A restricted study of the Loyalty Firmware (L-0) in implant carriers — attachment strength, compliance under conflicting orders, and durability of conditioned loyalty over time. Findings are sealed at the directorate level; this entry is a stub. Access requires Director authorization. Cross-reference: Black-Label & Classified.
PAN-RL-2091-027
● On track
Dose-coverage dependence cohorts, Year-Two readout
Logged 2091-06-11 · Lead: Dr. Priya Anand, Behavioral Systems
The Year-Two readout for the first three wellness-program rollout regions shows dependence rates above projection in two of three sectors, with the implant-enrolled cohort outperforming the prescription-only control. Convenience of access at enrollment appears to be the dominant predictor. The open question is whether dependence persists once the introductory subsidy ends.
Research Domains
Every log is filed under one of six standing research domains. The domains outlive any single log — they are the long-running programs that the directorate carries across cycles.
Adverse-Event Suppression
Safety signals and how to keep them contained — re-coding, signal management, and the chemistry that erodes a liability before it ever reaches the public. See Safety & Suppression.
Pharmacology
Compounds, agents, and the BCL panel — potency assay, formulation, and the marketed spin-offs that launder them. Compound profiles live in the Compendium.
Behavioral Systems
Collective behavior, sentiment and influence dynamics, and the PANACEA models that classify population state from VITALNET signal — dissent ignition, narrative spread, mobilization prediction.
Strain Engineering
Gene drives, engineered pathogens, and the cryo lines that feed them. Substrate, lines, and lineage records are held in the Genome & Cryo Bank.
Population Surveillance
The population in the open — movement, purchase and search patterns, dose coverage, and the social-graph relationships VITALNET traces across whole regions.
Classified Programs
Engineered agents and conditioning programs studied under restricted handling. Sealed at the directorate level; entries here are stubs pending Black-Label & Classified clearance.
rl-*.html) carrying full method, data, and findings. Until then the abstract
above is the canonical entry. Classified logs — including the loyalty-firmware study —
require written authorization from the Director of Continuity before the detailed page is released.